The information you will find on this page provide you with a closer look into our progress on identifying, prioritizing, designing and facilitating the implementation of solutions that drive efficient, effective and high-quality delivery of new medicines.
Find out what an eLabel is and how the TransCelerate eLabels Initiative will help advance the journey to a digitally-supported, patient-centric clinical supply chain.
What is an eLabel?
TransCelerate BioPharma Inc. has designed an example of an electronic label, or eLabel, for interaction with Health Authorities to show the “art of the possible.”
The Art of the Possible
This video describes the purpose of the Clinical Trial Registry of the Future concept and the principles of its design.
What is the Clinical Trial Registry of the Future?
This video highlights new ways patients might search for and narrow down clinical trial options, as demonstrated in the Clinical Trial Registry of the Future concept.
Searching for Clinical Trials
This video highlights information and features proposed in the Clinical Trial Registry of the Future concept aimed at providing patients a more robust experience when evaluating or considering a clinical trial.
Evaluating a Clinical Trial
See All Videos
In this video, we highlight what industry pain points our eConsent Initiative addresses and our latest resources to help guide implementation.
TransCelerate's eConsent Initiative
TransCelerate BioPharma Inc. is featured in PM360’s third annual Innovations in Pharma Marketing special issue as an innovative company in 2014. The article entitled “Innovators 2014: Companies” highlights how important innovation is to the success of the life science industry. The article provides a brief overview of TransCelerate and key accomplishments from the original five initiatives: Site Qualification & Training, Risk-Based Monitoring, Clinical Data Standards, Comparator Drug Network and Shared Investigator Platform.
LEARN MORE >
This Life Science Leader cover story is a comprehensive overview of TransCelerate Biopharma's founding and vision. The article is an interview with CEO Dalvir Gill, where he discusses the unmet needs TransCelerate is addressing, the power of collaboration among pharmaceutical companies, the organization’s different initiatives and how the key to overcoming skeptics lies in TransCelerate's ability to deliver results.
LEARN MORE >
This article reviews TransCelerate’s five key projects in its first year of operation. It also provides a discussion on its future initiatives. TransCelerate now has one of the most prized characteristics of successful organizations: the ability to deliver results on stated initiatives.
LEARN MORE >
You can search by Initiative or by Keyword
Follow Us on Twitter or Join Us on LinkedIn
Get updates from TransCelerate